Form D · Other
JUUL Labs, Inc.
Washington, D.C., DC · CIK 0001520049
Offering snapshot reported Nov 25, 2024 · SEC filing
- Reported sold
- $1.98B Offering amount: $1.98B
- Investors reported
- 138 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 27, 2023 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$1,277,229,601 → $1,984,355,731
- Reported investors26 → 138
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 25, 2024 | Amendment | $1,984,355,731 | $707,126,130vs May 28, 2024 | 138 | SEC filing |
| May 28, 2024 | Amendment | $1,277,229,601 | $7,229,604vs Nov 13, 2023 | 26 | SEC filing |
| Nov 13, 2023 | Initial | $1,269,999,997 | No comparison | 4 | SEC filing |
| Aug 8, 2022 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Feb 7, 2020 | Initial | $721,555,937 | No comparison | 20 | SEC filing |
| Aug 30, 2019 | Amendment | $785,176,874 | $460,176,874vs Aug 19, 2019 | 14 | SEC filing |
| Aug 19, 2019 | Initial | $325,000,000 | No comparison | 4 | SEC filing |
| Jul 10, 2018 | Initial | $650,000,000 | No comparison | 10 | SEC filing |
| Dec 19, 2017 | Initial | $111,500,000 | No comparison | 23 | SEC filing |
| Mar 17, 2017 | Amendment | $54,999,995 | $50,621,217vs Dec 28, 2016 | 34 | SEC filing |
| Dec 28, 2016 | Initial | $4,378,778 | No comparison | 2 | SEC filing |
| Jun 4, 2015 | Amendment | $46,685,837 | $40,185,837vs Apr 7, 2015 | 54 | SEC filing |
| Apr 7, 2015 | Initial | $6,500,000 | No comparison | 4 | SEC filing |
| May 6, 2011 | Initial | $3,230,163 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $610K
- Finders' fees
- $0
- Form D file number
- 021-497105
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Raine Securities LLC | 137873 | Raine Securities LLC · CRD 137873 |
| Papamarkou Wellner & Co., Inc. | 10963 | Papamarkou Wellner & Co., Inc. · CRD 10963 |
Source: Form D, filed Nov 25, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rona Ambrose | Director |
| Paul Aronzon | Director |
| David Barse | Director |
| Adam Bowen | Director |
| Kevin Burns | Director, Executive |
| K.C. Crosthwaite | Director, Executive |
| Timothy Danaher | Executive |
| Tom Dykstra | Director |
| Zachary Frankel | Director |
| Tyler Goldman | Executive |
| Ashley Gould | Executive |
| Harold Handelsman | Director |
| Ho Young Huh | Director |
| Vittal Kadapakkam | Executive |
| Joel Klein | Director |
| Tyler Mace | Executive |
| Gerald Masoudi | Executive |
| James Monsees | Director, Executive |
| Elaine Paik | Executive |
| Nicholas Pritzker | Director |
| Teresa Sebastian | Director |
| Saurabh Sinha | Executive |
| Riaz Valani | Director |
Issuer details
Industry: Other (See others in industry)
Address:
1000 F St Nw
Washington, D.C., DC, 20004
Washington, D.C., DC, 20004